Systemic inflammation alters central 5-HT function as determined by pharmacological MRI

NeuroImage

Volumn 75, Issue , 2013, Pages 177-186

  Couch, Yvonne ^a,b   Martin, Chris J ^b   Howarth, Clare ^b   Raley, Josie ^b   Khrapitchev, Alexandre A ^b   Stratford, Michael ^b   Sharp, Trevor ^a   Sibson, Nicola R ^b   Anthony, Daniel C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

BOLD fMRI; Inflammation; Rat; Serotonin

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FENFLURAMINE; MESSENGER RNA; SEROTONIN; SEROTONIN 2A RECEPTOR; VOLINANSERIN; FLUOROBENZENE; PIPERIDINE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BOLD SIGNAL; BRAIN REGION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; HORMONE ACTION; ILLNESS BEHAVIOR; INFLAMMATION; MALE; MICRODIALYSIS; MOTOR CORTEX; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PHARMACOLOGICAL MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATION; ANIMAL; AUTORADIOGRAPHY; BRAIN; BRAIN LEVEL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE PROCESSING; LASER DOPPLER FLOWMETRY; METABOLISM; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FENFLURAMINE; FLUOROBENZENES; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; LASER-DOPPLER FLOWMETRY; MAGNETIC RESONANCE IMAGING; MALE; MICRODIALYSIS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 84891462125     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.02.046     Document Type: Article

References (56)

1. Alesci S., Martinez P.E., Kelkar S., Ilias I., Ronsaville D.S., Listwak S.J., Ayala A.R., Licinio J., Gold H.K., Kling M.A., Chrousos G.P., Gold P.W. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J. Clin. Endocrinol. Metab. 2005, 90(5):2522-2530.
2. Anderson I.M., McKie S., Elliott R., Williams S.R., Deakin J.F. Assessing human 5-HT function in vivo with pharmacoMRI. Neuropharmacology 2008, 55(6):1029-1037.
3. Austin V.C., Blamire A.M., Grieve S.M., O'Neill M.J., Styles P., Matthews P.M., Sibson N.R. Differences in the BOLD fMRI response to direct and indirect cortical stimulation in the rat. Magn. Reson. Med. 2003, 49(5):838-847.
4. Balcioglu A., Wurtman R.J. Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: in vivo microdialysis study in conscious animals. Brain Res. 1998, 813(1):67-72.
5. Bhagwagar Z., Whale R., Cowen P.J. State and trait abnormalities in serotonin function in major depression. Br. J. Psychiatry 2002, 180:24-28.
6. Bhagwagar Z., Rabiner E.A., Sargent P.A., Grasby P.M., Cowen P.J. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol. Psychiatry 2004, 9(4):386-392.
7. Blamire A.M., Rothman D.L., Nixon T. Dynamic shim updating: a new approach towards optimized whole brain shimming. Magn. Reson. Med. 1996, 36(1):159-165.
8. Boothman L.J., Allers K.A., Rasmussen K., Sharp T. Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br. J. Pharmacol. 2003, 139(5):998-1004.
9. Brydon L., Harrison N.A., Walker C., Steptoe A., Critchley H.D. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol. Psychiatry 2008, 63(11):1022-1029.
10. Celada P., Puig M., Amargos-Bosch M., Adell A., Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J. Psychiatry Neurosci. 2004, 29(4):252-265.
11. Derijk R.H., Strijbos P.J., van Rooijen N., Rothwell N.J., Berkenbosch F. Fever and thermogenesis in response to bacterial endotoxin involve macrophage-dependent mechanisms in rats. Am. J. Physiol. 1993, 265(5 Pt 2):R1179-R1183.
12. Friston K.J., Holmes A.P., Worsley K.J., Poline J.-P., Frith C.D., Frackowiak R.S.J. Statistical Parametric Maps in Functional Imaging: A General Linear Approach. Hum. Brain Mapp. 1995, 2(4):189-210.
13. Gold L., Back T., Arnold G., Dreier J., Einhaupl K.M., Reuter U., Dirnagl U. Cortical spreading depression-associated hyperemia in rats: involvement of serotonin. Brain Res. 1998, 783(2):188-193.
14. Hajos N., Papp E.C., Acsady L., Levey A.I., Freund T.F. Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience 1998, 82(2):355-376.
15. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12(2):123-137.
16. Herwig U., Brauer K., Connemann B., Spitzer M., Schonfeldt-Lecuona C. Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology (Berl.) 2002, 164(2):228-232.
17. Hirani E., Sharp T., Sprakes M., Grasby P., Hume S. Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies. Synapse 2003, 50(3):251-260.
18. Horikawa N., Yamazaki T., Izumi N., Uchihara M. Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study. Gen. Hosp. Psychiatry 2003, 25(1):34-38.
19. Hughes M.M., Carballedo A., McLoughlin D.M., Amico F., Harkin A., Frodl T., Connor T.J. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain Behav. Immun. 2012, 26(6):979-987.
20. Javed A., Van de Kar L.D., Gray T.S. The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain. Brain Res. 1998, 791(1-2):67-74.
21. Jenkinson M., Beckmann C.F., Behrens T.E., Woolrich M.W., Smith S.M. FSL. NeuroImage 2012, 62(2):782-790.
22. Jennings K.A., Loder M.K., Sheward W.J., Pei Q., Deacon R.M., Benson M.A., Olverman H.J., Hastie N.D., Harmar A.J., Shen S., Sharp T. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J. Neurosci. 2006, 26(35):8955-8964.
23. Koch K.M., McIntyre S., Nixon T.W., Rothman D.L., de Graaf R.A. Dynamic shim updating on the human brain. J. Magn. Reson. 2006, 180(2):286-296.
24. Kouhata S., Kagaya A., Nakae S., Nakata Y., Yamawaki S. Effect of acute lipopolysaccharide administration on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane-induced wet dog shake behavior in rats: comparison with body weight change and locomotor activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25(2):395-407.
25. Kugaya A., Kagaya A., Uchitomi Y., Motohashi N., Yamawaki S. Inhibition of serotonin-induced Ca2+ mobilization by interleukin-1 beta in rat C6BU-1 glioma cells. Brain Res. 1995, 682(1-2):151-156.
26. Kugaya A., Kagaya A., Uchitomi Y., Yokota N., Yamawaki S. Effect of interferon-alpha on DOI-induced wet-dog shakes in rats. J. Neural Transm. 1996, 103(8-9):947-955.
27. Leonard B.E. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur. Psychiatry 2005, 20(Suppl. 3):S302-S306.
28. Levine J., Barak Y., Chengappa K.N., Rapoport A., Rebey M., Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999, 40(4):171-176.
29. Linthorst A.C., Flachskamm C., Muller-Preuss P., Holsboer F., Reul J.M. Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J. Neurosci. 1995, 15(4):2920-2934.
30. Logothetis N.K. What we can do and what we cannot do with fMRI. Nature 2008, 453(7197):869-878.
31. Lopez-Gimenez J.F., Mengod G., Palacios J.M., Vilaro M.T. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn Schmiedebergs Arch. Pharmacol. 1997, 356(4):446-454.
32. Manganotti P., Bortolomasi M., Zanette G., Pawelzik T., Giacopuzzi M., Fiaschi A. Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J. Neurol. Sci. 2001, 184(1):27-32.
33. Martin C., Jones M., Martindale J., Mayhew J. Haemodynamic and neural responses to hypercapnia in the awake rat. Eur. J. Neurosci. 2006, 24(9):2601-2610.
34. McKie S., Del-Ben C., Elliott R., Williams S., del Vai N., Anderson I., Deakin J.F. Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl.) 2005, 180(4):680-686.
35. Meyer J.H., Kapur S., Houle S., DaSilva J., Owczarek B., Brown G.M., Wilson A.A., Kennedy S.H. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. Am. J. Psychiatry 1999, 156(7):1029-1034.
36. Moresco R.M., Matarrese M., Fazio F. PET and SPET molecular imaging: focus on serotonin system. Curr. Top. Med. Chem. 2006, 6(18):2027-2034.
37. Murphy S.E., Norbury R., O'Sullivan U., Cowen P.J., Harmer C.J. Effect of a single dose of citalopram on amygdala response to emotional faces. Br. J. Psychiatry 2009, 194(6):535-540.
38. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14(5):511-522.
39. Paxinos G., Watson C.R., Emson P.C. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J. Neurosci. Methods 1980, 3(2):129-149.
40. Preece M.A., Taylor M.J., Raley J., Blamire A., Sharp T., Sibson N.R. Evidence that increased 5-HT release evokes region-specific effects on blood-oxygenation level-dependent functional magnetic resonance imaging responses in the rat brain. Neuroscience 2009, 159(2):751-759.
41. Ramamoorthy S., Ramamoorthy J.D., Prasad P.D., Bhat G.K., Mahesh V.B., Leibach F.H., Ganapathy V. Regulation of the human serotonin transporter by interleukin-1 beta. Biochem. Biophys. Res. Commun. 1995, 216(2):560-567.
42. Rauch A., Rainer G., Logothetis N.K. The effect of a serotonin-induced dissociation between spiking and perisynaptic activity on BOLD functional MRI. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(18):6759-6764.
43. Rosengarten B., Hecht M., Wolff S., Kaps M. Autoregulative function in the brain in an endotoxic rat shock model. Inflamm. Res. 2008, 57(11):542-546.
44. Rosengarten B., Walberer M., Allendoerfer J., Mueller C., Schwarz N., Bachmann G., Gerriets T. LPS-induced endotoxic shock does not cause early brain edema formation - an MRI study in rats. Inflamm. Res. 2008, 57(10):479-483.
45. Sawyer E.K., Mun J., Nye J.A., Kimmel H.L., Voll R.J., Stehouwer J.S., Rice K.C., Goodman M.M., Howell L.L. Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use. Neuropsychopharmacology 2012, 37(8):1816-1824.
46. Series H.G., Cowen P.J., Sharp T. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology (Berl.) 1994, 116(4):508-514.
47. Sharp T., Boothman L., Raley J., Queree P. Important messages in the 'post': recent discoveries in 5-HT neurone feedback control. Trends Pharmacol. Sci. 2007, 28(12):629-636.
48. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004, 23(Suppl. 1):S208-S219.
49. Stein D.J., Hemmings S., Moolman-Smook H., Audenaert K. 5-HT2A: its role in frontally mediated executive function and related psychopathology. CNS Spectr. 2007, 12(7):512-516.
50. Varga V., Szekely A.D., Csillag A., Sharp T., Hajos M. Evidence for a role of GABA interneurones in the cortical modulation of midbrain 5-hydroxytryptamine neurones. Neuroscience 2001, 106(4):783-792.
51. Ward R.P., Dorsa D.M. Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum. J. Comp. Neurol. 1996, 370(3):405-414.
52. Watanabe Y., Sakai R.R., McEwen B.S., Mendelson S. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res. 1993, 615(1):87-94.
53. Wilkinson L.O., Auerbach S.B., Jacobs B.L. Extracellular serotonin levels change with behavioral state but not with pyrogen-induced hyperthermia. J. Neurosci. 1991, 11(9):2732-2741.
54. Woolrich M.W., Jbabdi S., Patenaude B., Chappell M., Makni S., Behrens T., Beckmann C., Jenkinson M., Smith S.M. Bayesian analysis of neuroimaging data in FSL. Neuroimage 2009, 45(Suppl. 1):S173-S186.
55. Zhang Y.Q., Gao X., Ji G.C., Huang Y.L., Wu G.C. Expression of 5-HT2A receptor mRNA in rat nucleus raphe magnus neurons after peripheral inflammation. Acta Pharmacol. Sin. 2001, 22(10):923-928.
56. Zhu C.B., Lindler K.M., Owens A.W., Daws L.C., Blakely R.D., Hewlett W.A. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 2010, 35(13):2510-2520.